Augusto Ochoa

Immunology · 2004–2016

A researcher in the Science corpus: 8 papers; trusts 7 researchers and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 78 citations into it; #309 of 2,160 by trust here, #348 by citations
• Oncology — 34 citations into it

Whom Augusto Ochoa trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Rodriguez
2. V. Bronte
3. D. Munn
4. P. Serafini
5. A. Mellor

Who trusts Augusto Ochoa overall

1. D. Gabrilovich
2. M. Munder
3. D. Munn
4. S. Nagaraj
5. T. Condamine

Papers from Augusto Ochoa's perspective

Ordered by how strongly the researchers Augusto Ochoa trusts endorse each paper. Same corpus, a different order for every researcher.

1. Immunosuppressive networks in the tumour environment and their therapeutic relevance (Nature Reviews. Cancer)
2. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 (Journal of Immunology)
3. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
4. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. (Cancer Research)
5. Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses (Cancer Research)
6. Altered macrophage differentiation and immune dysfunction in tumor development. (Journal of Clinical Investigation)
7. Inflammation and cancer: back to Virchow? (The Lancet)
8. Immunosuppressive strategies that are mediated by tumor cells. (Annual Review of Immunology)
9. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells (Nature Medicine)
10. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function (Journal of Experimental Medicine)

Their papers

• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards (2016) — 2,457 citations
• Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes (2009) — 789 citations
• Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives (2008) — 722 citations
• L-arginine availability regulates T-lymphocyte cell-cycle progression. (2007) — 921 citations
• B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma (2006) — 761 citations
• Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma (2005) — 630 citations
• Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. (2005) — 896 citations
• Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses (2004) — 1,236 citations